Skip to content

Free cash flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.47B-56.6%
AbbVie logo
AbbVieABBV
$3.56B+155%
Medtronic logo
MedtronicMDT
$2.09B+0.8%
GLW
CorningGLW
$30M+153%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$1.1B+7.9%
Gross profit$735.4M+8.3%
Operating income-$31.0M-117%
Net income-$77.9M-189%
EPS (diluted)-$0.40-191%

Balance sheet

See full
Cash & equivalents$139.0M+19.6%
Total debt$3.1B+15.6%
Total equity$8.2B-0.6%
Total assets$12.5B+0.6%

Cash flow

See full
Operating cash flow$182.8M+90.0%
CapEx$86.4M+10.6%

Valuation

See full
Market cap$12.85B-25.7%
Enterprise value$15.78B-20.2%
P/E54.5×+12.8×
P/S-1.3×

Profitability

See full
Gross margin65.5%-1.6pp
Operating margin11.8%-7.2pp
Net margin5.6%-4.8pp
FCF margin13.5%+4.3pp

Returns & leverage

See full
Return on equity2.9%-2.3pp
Debt / equity0.4×+0.1×
Current ratio1.3×-0.8×

Where this comes from

Calculated from The Cooper Companies, Inc.’s reported figures.

The official record: The Cooper Companies, Inc.’s 10-Q, filed June 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Cooper Companies, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Cooper Companies, Inc.'s free cash flow?
The Cooper Companies, Inc. (COO) reported free cash flow of $96.4M in Q1 2026.
How has The Cooper Companies, Inc.'s free cash flow changed year-over-year?
The Cooper Companies, Inc.'s free cash flow increased by 432.6% year-over-year, from $18.1M to $96.4M.
What is the long-term trend for The Cooper Companies, Inc.'s free cash flow?
Over 4 years (2021 to 2025), The Cooper Companies, Inc.'s free cash flow has grown at a -4.6% compound annual growth rate (CAGR), from $524.2M to $433.7M.